ReproCELL Incorporated (4978.T)

JPY 145.0

(6.62%)

Long Term Debt Summary of ReproCELL Incorporated

  • ReproCELL Incorporated's latest annual long term debt in 2023 was - JPY , down 0.0% from previous year.
  • ReproCELL Incorporated's latest quarterly long term debt in 2024 Q1 was - JPY , down 0.0% from previous quarter.
  • ReproCELL Incorporated reported annual long term debt of - JPY in 2022, down 0.0% from previous year.
  • ReproCELL Incorporated reported annual long term debt of - JPY in 2021, down -100.0% from previous year.
  • ReproCELL Incorporated reported quarterly long term debt of - JPY for 2023 Q3, down 0.0% from previous quarter.
  • ReproCELL Incorporated reported quarterly long term debt of - JPY for 2023 Q4, down 0.0% from previous quarter.

Annual Long Term Debt Chart of ReproCELL Incorporated (2023 - 2011)

Historical Annual Long Term Debt of ReproCELL Incorporated (2023 - 2011)

Year Long Term Debt Long Term Debt Growth
2023 - JPY 0.0%
2022 - JPY 0.0%
2021 - JPY -100.0%
2020 80 Million JPY 0.0%
2019 80 Million JPY 0.0%
2018 80 Million JPY 0.0%
2017 80 Million JPY -3.44%
2016 82.85 Million JPY -3.59%
2015 85.93 Million JPY 7.42%
2014 80 Million JPY 0.0%
2013 80 Million JPY 0.0%
2012 80 Million JPY 0.0%
2011 - JPY 0.0%

Peer Long Term Debt Comparison of ReproCELL Incorporated

Name Long Term Debt Long Term Debt Difference
KOHJIN BIO CO LTD 767.03 Million JPY 100.0%
PRISM BioLab Co.,LTD - JPY NaN%
GNI Group Ltd. 2 Billion JPY 100.0%
Linical Co., Ltd. 1.49 Billion JPY 100.0%
Trans Genic Inc. 1.32 Billion JPY 100.0%
MEDINET Co., Ltd. 781 Thousand JPY 100.0%
Soiken Holdings Inc. - JPY NaN%
Cytori Cell Research Institute, Inc. 2.34 Billion JPY 100.0%
AnGes, Inc. 214.94 Million JPY 100.0%
OncoTherapy Science, Inc. 106.84 Million JPY 100.0%
Nxera Pharma Co., Ltd. 63.21 Billion JPY 100.0%
Immuno-Biological Laboratories Co., Ltd. 84.56 Million JPY 100.0%
NanoCarrier Co., Ltd. 1.1 Billion JPY 100.0%
Carna Biosciences, Inc. 28.4 Million JPY 100.0%
CanBas Co., Ltd. - JPY NaN%
D. Western Therapeutics Institute, Inc. 875.59 Million JPY 100.0%
RaQualia Pharma Inc. 39.05 Million JPY 100.0%
Chiome Bioscience Inc. - JPY NaN%
Kidswell Bio Corporation 1.83 Billion JPY 100.0%
PeptiDream Inc. 19.63 Billion JPY 100.0%
Oncolys BioPharma Inc. 161.1 Million JPY 100.0%
Ribomic Inc. - JPY NaN%
SanBio Company Limited 397 Million JPY 100.0%
Healios K.K. 450 Million JPY 100.0%
BrightPath Biotherapeutics Co., Ltd. - JPY NaN%
Kubota Pharmaceutical Holdings Co., Ltd. - JPY NaN%
Delta-Fly Pharma, Inc. - JPY NaN%
StemRIM - JPY NaN%
CellSource Co., Ltd. 77.29 Million JPY 100.0%
FunPep Company Limited - JPY NaN%
Kringle Pharma, Inc. - JPY NaN%
Stella Pharma Corporation 773.29 Million JPY 100.0%
TMS Co., Ltd. - JPY NaN%
Noile-Immune Biotech Inc. - JPY NaN%
Cuorips Inc. - JPY NaN%
K Pharma,Inc. - JPY NaN%
Takara Bio Inc. 788 Million JPY 100.0%
PhoenixBio Co., Ltd. 491.35 Million JPY 100.0%
StemCell Institute Inc. 6.67 Million JPY 100.0%
Japan Tissue Engineering Co., Ltd. - JPY NaN%
CellSeed Inc. 143.75 Million JPY 100.0%